AbbVie: 5 Reasons That Make A Buy Case (NYSE:ABBV)

vzphotos Since I last wrote about the pharmaceuticals company AbbVie Inc. (NYSE:ABBV) in March, its stock market performance has been underwhelming, with a 3% price decline. This isn’t an entirely surprising short-term movement. The stock was trading at higher multiples compared with its five-year average levels three months ago. The stock’s price performance was also…

Read More

Coursera: A Good Contrarian Buy (NYSE:COUR)

Sundry Photography Investment Thesis Coursera, Inc. (NYSE:COUR) has good growth prospects ahead. The company’s revenue growth should benefit from strong demand for professional certifications driven by the rising need for reskilling and upskilling. This demand should further be supported by increasing certifications by renowned industry partners, which should continue to boost new learner registration and…

Read More

Devon’s Undervaluation Remains A Boon As Management Executes Brilliantly – Reiterate Buy

boygovideo We previously covered Devon Energy (NYSE:DVN) in March 2024, discussing its inherent undervaluation compared to its peers, despite the healthier balance sheet, raised fixed dividends, and sustained share retirement. With a prospective market re-rating likely to bring forth excellent upside potential as the elevated crude oil prices triggered higher variable dividends, we believed that…

Read More

ARMOUR Residential REIT Series C: Buy While We Wait On Interest Rates (NYSE:ARR.PR.C)

DNY59 June 7th’s surprisingly strong jobs report was the latest data point to dampen hopes for any near-term reduction in interest rates. Wednesday’s Bureau of Labor Statistics’ May CPI report showed moderating inflation, but the Federal Reserve’s two-day policy meeting comments postponed any rate cuts. Meanwhile, all varieties of income-oriented investors continued what has become…

Read More

Enfusion: Expectation Of Faster Growth And Higher Margins Justify Buy Rating (NYSE:ENFN)

amgun Elevator Pitch I have a Buy rating assigned to Enfusion, Inc. (NYSE:ENFN) shares. My prior write-up published on November 8, 2023 highlighted Enfusion’s above-expectations financial performance for the third quarter of last year. In the current article, I have found good reasons to be optimistic about ENFN’s prospects pertaining to revenue growth acceleration and…

Read More

MicroStrategy Boosts Stock Sale to $700M to Buy More Bitcoin

MicroStrategy, led by CEO Michael Saylor, has increased the size of its planned stock sale to raise additional funds to purchase Bitcoin. The company is now seeking to raise $700 million, up from the previously announced $500 million. JUST IN: Michael Saylor says, "I'll be buying #Bitcoin when it's $8 million.” 🙌 pic.twitter.com/k5cEEQedGZ — Bitcoin…

Read More

Buy 9 Sustainable Dividend Dogs Of Barron’s June Top 100

Ralf Hahn/iStock via Getty Images Foreword This article is based on 100 top sustainable companies based on Calvert Research and Management’s annual review of more than 230 Environmental, Social and Governance [ESG] performance indicators, such as workplace diversity, data security, and greenhouse-gas emissions, as reported in the February 26, 2024, edition of Barron’s weekly. How…

Read More

Michael Saylor’s MicroStrategy To Raise $500M To Buy More Bitcoin

MicroStrategy, led by CEO Michael Saylor, announced it will raise $500 million through a private offering of convertible senior notes. The proceeds will fund additional purchases, furthering its corporate Bitcoin accumulation strategy. BREAKING: 🇺🇸 MICROSTRATEGY TO RAISE $500 MILLION IN STOCK SALE TO BUY MORE #BITCOIN pic.twitter.com/ALsb7znGEZ — Bitcoin Magazine (@BitcoinMagazine) June 13, 2024 MicroStrategy…

Read More

Outlook Therapeutics: Speculative Buy With High Stakes In Anti-VEGF Market (NASDAQ:OTLK)

Zorica Nastasic Outlook Therapeutics (NASDAQ:OTLK) is a late clinical-stage biopharmaceutical company focusing on ONS-5010/LYTENAVA (bevacizumab-vikg) indicated for retinal conditions such as wet age-related macular degeneration [wet AMD], diabetic macular edema [DME], and branch retinal vein occlusion [BRVO]. The company is resubmitting a BLA for ONS-5010 at the end of 2024 after executing an FDA-recommended non-inferiority…

Read More

Upstart: Buy Weakness (Rating Upgrade) (NASDAQ:UPST)

mesh cube/iStock via Getty Images While the personal loans business has been tough the last couple of years since the Fed starting hiking interest rates, Upstart Holdings, Inc. (NASDAQ:UPST) always sees outsized gains on excitement over their AI lending model. The stock has again slumped to the low $20s where the valuation is more appealing….

Read More

VYMI: A Strong Buy On Dips With A 4.8% Yield

Nikada Vanguard International High Dividend Yield Index Fund ETF Shares (NASDAQ:VYMI) primarily invests in foreign large cap value stocks that offer a high-yielding dividend. Since many European stocks offer a higher yield than their U.S. counterparts, this fund has strong European exposure and an impressive yield of about 4.8%. There is a lot to like…

Read More

Broadcom: Compelling Buy, Thanks To Raised AI Guidance (NASDAQ:AVGO)

photoschmidt/iStock via Getty Images We previously covered Broadcom (NASDAQ:NASDAQ:AVGO) in February 2024, discussing why we had finally upgraded the stock as a Buy, after multiple rounds of Hold rating. This was attributed to its reasonable FWD valuations compared to its peers and the management’s highly optimistic FY2024 forward guidance, with the consensus already moderately raising…

Read More

KWEB: Upgrade To BUY, Too Cheap To Ignore (NYSEARCA:KWEB)

William_Potter Introduction Is China investible, that’s the first question one may ask before considering buying into this market. The answer is yes with two important caveats; 1. that the stocks have 20Fs i.e. some reasonable sense of disclosure and audited financials and 2. that the valuations compensate for the many other China factors. Those China…

Read More

Booking Soars On Growth, Eye On Valuation, Cautious Buy (NASDAQ:BKNG)

FG Trade Latin Investment Thesis Booking Holdings (NASDAQ:BKNG), the travel giant behind Booking.com, Priceline, and Kayak, reported strong first quarter in 2024. Revenue climbed 17% YoY to $4.4 billion, exceeding analysts expectations. Earnings per share (EPS) also jumped significantly to $20.39, compared to $7.07 in Q1 2023. Gross travel bookings reached $43.5 billion, reflecting a…

Read More

Celsius Holdings: Buy This Deep Pullback – Growth Story Remains Robust (NASDAQ:CELH)

MicroStockHub We previously covered Celsius Holdings, Inc. (NASDAQ:CELH) in March 2024, discussing why it might be the next big thing in the global energy drink market, attributed to its impressive share gains against incumbents, such as Monster Beverage Corporation (MNST) and Red Bull. Much of the tailwinds were attributed to successful marketing efforts, strategic partnerships,…

Read More

Semler Scientific To Raise $150M To Buy More Bitcoin

Medical device manufacturer Semler Scientific (Nasdaq: SMLR) announced it acquired 247 additional Bitcoin for $17 million in cash, bringing its total holdings to 828 BTC. The company also plans to raise $150 million to expand its Bitcoin reserves. JUST IN: BlackRock spot #Bitcoin ETF IBIT had $347.1 million inflows today. pic.twitter.com/SIKByVcctA — Bitcoin Magazine (@BitcoinMagazine)…

Read More

Is Ultra-Cheap Jackson Financial A Buy? (NYSE:JXN)

Guido Mieth Article Thesis Jackson Financial Inc. (NYSE:JXN) has delivered a very nice 150%+ return over the last year, and yet, its valuation is still very low. In this article, we will take a look at the company’s business model, opportunities, and whether Jackson Financial is a good investment at current prices. Past Coverage I…

Read More

Robinhood To Buy Bitcoin and Crypto Exchange Bitstamp For $200M

Robinhood has agreed to acquire leading Bitcoin and crypto exchange Bitstamp for $200 million in cash, marking a major expansion of its Bitcoin and crypto business. The deal is expected to close in the first half of 2025. BREAKING: ROBINHOOD BUYS #BITCOIN AND CRYPTO EXCHANGE BITSTAMP FOR $200 MILLION. pic.twitter.com/Q9LfBDw3Di — Bitcoin Magazine (@BitcoinMagazine) June…

Read More

Digital Realty: Still Too Expensive To Buy (NYSE:DLR)

Erik Isakson/DigitalVision via Getty Images Summary In our initial report on Digital Realty (NYSE:DLR), we rated the shares a Hold on valuation. We believed they were “too expensive to consider a Buy”, though we acknowledged that the near-term fundamentals of the DC market were too strong to allow significant underperformance. We have updated our valuation…

Read More

Stellantis: A Strong Buy Amidst Industry Turbulence (NYSE:STLA)

jetcityimage Market Dynamics and Industry Challenges The auto sector is notorious for its competitive margins, and with the evolution towards electric vehicles (EVs), companies lagging in innovation are finding it particularly tough. Stellantis N.V. (NYSE:STLA), despite its efforts, is among those caught behind, which is evident from the struggle to compete with industry leaders like…

Read More

Grab Stock: 7.5 Reasons To Buy

Kokkai Ng Introduction Grab (NASDAQ:GRAB), the so-called Uber (UBER) of Southeast Asia, has been trading range-bound between $2 and $4 for nearly two years now. However, the stock is quietly up 11% YTD as it approaches a key resistance level. Short-term bulls might consider taking profits while bears might argue that Grab stock is pretty…

Read More

If I Could Only Buy 2 High Dividend Yield Companies In June 2024

BrettCharlton Investment Thesis Including high dividend yield companies in your investment portfolio brings you several benefits as an investor. This includes the generation of income, a reduction in portfolio volatility, and an elevated independence from stock market price fluctuations. However, these benefits come with certain risks, primarily the potential for dividend reductions, which can negatively…

Read More

Everything On My Buy List For The First Week Of June

cagkansayin/iStock via Getty Images I have a riddle for you. Total employment is near an all-time high. Wages are rising faster than inflation. Retail sales remain robust. Airline travel is reaching record levels and expected to go even higher this summer. The stock market is within a few percentage points of all-time highs. It was…

Read More

Why This Could Be A Great Time To Buy China (FXI)

EschCollection China’s government has been stubborn in its refusal to offer large stimulus measures to arrest the country’s economic decline. This has ended in 2024 with some “historic” changes. Investment managers are flooding back to China, and the recent plunge in the country’s currency has made the opportunity more enticing. China’s government steps in to…

Read More

Unity: New Management Has A Plan; Speculative Buy (NYSE:U)

Jose Luis Pelaez Inc/DigitalVision via Getty Images Investment Thesis Unity Software (NYSE:U) provides a powerful platform for creators to build interactive content across various devices. Their suite includes Create Solutions for development and Grow solutions for user engagement and monetization. 2024 has been a challenging year for Unity. Despite exceeding revenue expectations by 200% in…

Read More